| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Elevation Oncology, Inc. | CHIEF MEDICAL OFFICER | Restricted Stock Unit | 70,000 | $193,900 | $2.77 | 15 Feb 2024 | Direct |
| Elevation Oncology, Inc. | CHIEF MEDICAL OFFICER | Restricted Stock Unit | 52,500 | $35,264 | $0.6717 | 15 Feb 2024 | Direct |
| Elevation Oncology, Inc. | CHIEF MEDICAL OFFICER | Common Stock | 12,311 | $8,269 | $0.6717 | 15 Feb 2025 | Direct |
| Elevation Oncology, Inc. | CHIEF MEDICAL OFFICER | Stock Option (Right to Buy) | 275,000 | 15 Feb 2025 | Direct | ||
| OnKure Therapeutics, Inc. | Director | Stock Option (right to buy) | 7,650 | 28 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OKUR | OnKure Therapeutics, Inc. | 28 May 2025 | 1 | $0 | 4 | Director | 30 May 2025, 16:52 |
| ELEV | Elevation Oncology, Inc. | 15 Feb 2025 | 4 | -$3,485 | 4 | CHIEF MEDICAL OFFICER | 19 Feb 2025, 16:25 |
| OKUR | OnKure Therapeutics, Inc. | 04 Oct 2024 | 1 | $0 | 4 | Director | 08 Oct 2024, 19:25 |
| OKUR | OnKure Therapeutics, Inc. | 04 Oct 2024 | 0 | $0 | 3 | Director | 08 Oct 2024, 19:09 |
| ELEV | Elevation Oncology, Inc. | 15 Feb 2024 | 2 | $0 | 4 | CHIEF MEDICAL OFFICER | 20 Feb 2024, 17:02 |
| ELEV | Elevation Oncology, Inc. | 15 Feb 2023 | 1 | $0 | 4 | CHIEF MEDICAL OFFICER | 17 Feb 2023, 15:29 |
| ELEV | Elevation Oncology, Inc. | 06 Jan 2023 | 1 | $0 | 4 | CHIEF MEDICAL OFFICER | 10 Jan 2023, 15:30 |
| ELEV | Elevation Oncology, Inc. | 14 Feb 2022 | 1 | $0 | 4 | Chief Medical Officer | 16 Feb 2022, 19:09 |
| ELEV | Elevation Oncology, Inc. | 19 Oct 2021 | 1 | $0 | 4 | Chief Medical Officer | 21 Oct 2021, 18:32 |
| ELEV | Elevation Oncology, Inc. | 19 Oct 2021 | 0 | $0 | 3 | Chief Medical Officer | 21 Oct 2021, 18:29 |